| Segment Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
Sep 27, 2014 |
|
Sep 28, 2013 |
|
Sep 27, 2014 |
|
Sep 28, 2013 |
Net sales |
|
|
|
|
|
|
|
Metals Segment |
$ |
32,899,000 |
|
|
$ |
35,163,000 |
|
|
$ |
102,091,000 |
|
|
$ |
108,720,000 |
|
Specialty Chemicals Segment |
15,553,000 |
|
|
14,049,000 |
|
|
48,845,000 |
|
|
41,630,000 |
|
|
$ |
48,452,000 |
|
|
$ |
49,212,000 |
|
|
$ |
150,936,000 |
|
|
$ |
150,350,000 |
|
Operating income |
|
|
|
|
|
|
|
|
|
Metals Segment |
$ |
3,840,000 |
|
|
$ |
517,000 |
|
|
$ |
11,000,000 |
|
|
$ |
3,148,000 |
|
Specialty Chemicals Segment |
1,416,000 |
|
|
1,576,000 |
|
|
4,772,000 |
|
|
4,466,000 |
|
|
5,256,000 |
|
|
2,093,000 |
|
|
15,772,000 |
|
|
7,614,000 |
|
Unallocated expenses |
|
|
|
|
|
|
|
Corporate |
549,000 |
|
|
824,000 |
|
|
2,503,000 |
|
|
2,443,000 |
|
Acquisition related costs |
— |
|
|
152,000 |
|
|
(3,000 |
) |
|
203,000 |
|
Interest expense |
261,000 |
|
|
362,000 |
|
|
789,000 |
|
|
1,077,000 |
|
Change in fair value of interest rate swap |
(103,000 |
) |
|
106,000 |
|
|
192,000 |
|
|
(527,000 |
) |
Palmer earn-out adjustment |
— |
|
|
— |
|
|
(3,476,000 |
) |
|
— |
|
Bargain gain on CRI acquisition |
— |
|
|
(1,077,000 |
) |
|
— |
|
|
(1,077,000 |
) |
Income from continuing operations |
|
|
|
|
|
|
|
before income taxes |
$ |
4,549,000 |
|
|
$ |
1,726,000 |
|
|
$ |
15,767,000 |
|
|
$ |
5,495,000 |
|
|